Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB08925_nanopub.RAS-33VzRoGbgLo08C7YkdDuZNLWA0OYjzOLPhn1a9eFY#assertion>. }
Showing items 1 to 13 of
13
with 100 items per page.
- drugbank:DB08925 type drugbank_vocabulary:Drug assertion.
- drugbank:DB08925 label "Adrafinil [drugbank:DB08925]" assertion.
- drugbank:DB08925 seeAlso DB08925 assertion.
- drugbank:DB08925 description "Adrafinil is a mild central nervous system stimulant drug used to relieve excessive sleepiness and inattention in elderly patients. It is also used off-label by individuals wishing to avoid fatigue, such as night workers or others who need to stay awake and alert for long periods of time. Adrafinil does not currently have FDA approval and is thus unregulated in the United States. It was marketed in France and elsewhere in Europe under the trade name Olmifon until September 2011 when France's FDA equivalent reassessed the drug and withdrew marketing permission. [Wikipedia]" assertion.
- drugbank:DB08925 identifier "drugbank:DB08925" assertion.
- drugbank:DB08925 title "Adrafinil" assertion.
- drugbank:DB08925 drugbank_vocabulary:x-cas cas:63547-13-7 assertion.
- drugbank:DB08925 drugbank_vocabulary:drugbank-id "DB08925" assertion.
- drugbank:DB08925 bio2rdf_vocabulary:x-identifiers.org DB08925 assertion.
- drugbank:DB08925 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB08925" assertion.
- drugbank:DB08925 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB08925 bio2rdf_vocabulary:identifier "DB08925" assertion.
- drugbank:DB08925 drugbank_vocabulary:x-kegg kegg:D07348 assertion.